| Literature DB >> 26771114 |
Adil Mardinoglu1, Jan Boren2, Ulf Smith3.
Abstract
Type 2 diabetes (T2D) is associated with dysbiosis of the gut microbiota, though diabetes treatment regimens, including metformin, may confound the results. Forslund et al. (2015) identify distinct disease and drug signatures and highlight the importance of adjusting for treatment when investigating how T2D influences the human gut microbiome.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26771114 DOI: 10.1016/j.cmet.2015.12.012
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287